Four numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 23 other studies
the abstract, start to end
… who achieved HbA1c < 7.0% [RR 2.26, 95% CI (1.89, 2.70), …
… incidence of adverse events (AEs) [RR 1.06, 95% CI (1.02, 1.11), p < 0.0001] and an analogous incidence in serious adverse events (SAEs) [RR 0.94, 95% CI (0.86, 1.02), p = 0.11] and hypoglycaemic events (severe or blood glucose (BG)-confirmed symptomatic) [RR 0.93, 95% CI (0.74, 1.16), p = 0.50] …
← favours treatmentfavours comparator →
could be chanceGlycemic control
RR 2.261.89–2.70
Adverse events & safety
RR 1.061.02–1.11
Adverse events & safety
RR 0.940.86–1.02
Glycemic control
RR 0.930.74–1.16
GLP-1 receptor agonistsGlycemic controlAdverse events & safety
GLP-1 receptor agonists × adverse events & safetyharms?mixed
unlikelylikely
0.00not counted
GLP-1 receptor agonists × glycemic controlhelps?replicated
unlikelylikely
0.90not counted
← favours treatmentfavours comparator →
1 / 5